Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

被引：0
|
作者：
F Pauly
K Fjordén
S Leppä
H Holte
M Björkholm
Ø Fluge
L Møller Pedersen
M Eriksson
A Isinger-Ekstrand
C A K Borrebaeck
M Jerkeman
C Wingren
机构：
[1] Lund University,Department of Immunotechnology
[2] CREATE Health,Department of Oncology
[3] Lund University,Department of Oncology
[4] Lund University,Department of Oncology
[5] Skåne University Hospital,Department of Medicine
[6] Helsinki University Hospital,Department of Oncology
[7] Oslo University Hospital,Department of Hematology
[8] Karolinska University Hospital,undefined
[9] Haukeland University Hospital,undefined
[10] Roskilde Hospital,undefined
来源：
Blood Cancer Journal | 2016年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e501 / e501
相关论文
共 50 条
  • [31] Diffuse large B-cell lymphoma
    Martelli, Maurizio
    Ferreri, Andres J. M.
    Agostinelli, Claudio
    Di Rocco, Alice
    Pfreundschuh, Michael
    Pileri, Stefano A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 87 (02) : 146 - 171
  • [32] Diffuse large B-cell lymphoma
    Decool, Gauthier
    Theves, Floriane
    HEMATOLOGIE, 2018, 24 : 35 - 40
  • [33] Diffuse Large B-Cell Lymphoma
    Lang, Raynell
    Gill, M. John
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23): : 2261 - 2262
  • [34] Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    Fisher, Richard I.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2008, 22 (05) : 941 - +
  • [35] Diffuse large B-cell lymphoma
    Shahi, Parham Khosravi
    Manga, Gumersindo Perez
    MEDICINA CLINICA, 2006, 127 (01): : 17 - 21
  • [36] Diffuse large B-cell lymphoma
    Alcantara, Marion
    Huynh, Tony
    HEMATOLOGIE, 2016, 22 (02): : 159 - 166
  • [37] Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma
    Mandi, Y.
    Malihy, A.
    Kettani, F.
    Alaammari, I.
    Khmou, M.
    Touri, S.
    Rouas, L.
    Lamalmi, N.
    El Khorassani, M.
    Alhamany, Z.
    ARCHIVES DE PEDIATRIE, 2015, 22 (06): : 661 - 664
  • [38] Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group
    Jurczak, Wojciech
    Ochrem, Bogdan
    Giza, Agnieszka
    Zimowska-Curylo, Dagmara
    Gorecki, Tomasz
    Boguradzki, Piotr
    Knopinska-Posluszny, Wanda
    Stella-Holowiecka, Beata
    Walewski, Jan
    Joks, Monika
    Wrobel, Tomasz
    Zaucha, Jan M.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 741 - 748
  • [39] Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study
    Hudson, Kathryn E.
    Rizzieri, David
    Thomas, Samantha M.
    LeBlanc, Thomas W.
    Powell, Zachary
    Diehl, Louis
    Moore, Joseph O.
    DeCastro, Carlos
    Beaven, Anne W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) : 647 - 650
  • [40] Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
    Fjorden, Karin
    Ekberg, Sara
    Kuric, Nevzeta
    Smedby, Karin E.
    Lagerlof, Ingemar
    Larsen, Thomas S.
    Jorgensen, Judit M.
    de Nully Brown, Peter
    Jerkeman, Mats
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (02) : 437 - 440
12345